Combination therapy with lenvatinib and radiofrequency ablation for patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and child–pugh class a liver function: a pilot study

HIGHLIGHTS

• who: Feiqian Wang and colleagues from the Catholic University of, Zhejiang University, China have published the research: Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Childu2013Pugh Class A Liver function: A Pilot Study, in the Journal: (JOURNAL) of February/22,/2022
• what: Excitingly, the study obtained many positive results that were obtained due to the addition of RFA.
• how: Continuous variables when normally distributed are described as the means and standard deviation while when non-normally distributed data are presented as . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.